Superior Planning, LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Superior Planning, LLC’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.27K	Buy	+6	New	+$2.09K	﹤0.01%	1521

Other funds holding BIO

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

First Pacific Advisors El Segundo, California $8.39B AUM 15.4% 1-Year Est. Return

Superior Planning, LLC's BIO Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 6 shares worth $2.27K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings.

276 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

Superior Planning, LLC held 6 shares of Bio-Rad Laboratories Class A worth $2.27K as of Q3 2026.
Bio-Rad Laboratories Class A was a new Superior Planning, LLC position in Q3 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1521 holding.
276 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.